Fella Health logo

Fella Health

Challenger

SF YC W20/S21 men's GLP-1 obesity telemedicine at $50M+ ARR cashflow positive 24 months with $130K total raised; competing with Ro and Hims for men's obesity treatment at massive capital efficiency targeting 1M patients by end 2026.

61
AI Score
Grade B
AI Visibility Score (Beta)
HealthcareWebsiteUpdated March 2026

Company Overview

About Fella Health

Fella Health is a San Francisco-based men's obesity telemedicine platform — bootstrapped with minimal external funding ($130,000 seed from Y Combinator, Global Founders Capital, AngelList, and founders of Indeed, Curative, and Alan) — providing men with obesity and metabolic health challenges with a subscription-based direct-to-patient treatment program combining FDA-approved GLP-1 medications (semaglutide and tirzepatide), psychological strengthening, and behavioral interventions for significant weight loss and metabolic health improvement. Having achieved over $50 million in annual recurring revenue and cashflow positive operations for 24 months, with 76+ employees and a mission to serve 1 million men by end of 2026, Fella also operates Delilah Health for women through the same clinical model. Y Combinator W20/S21 backed.

Business Model & Competitive Advantage

Fella Health's men's obesity telemedicine model capitalizes on the GLP-1 medication revolution in obesity treatment while adding the behavioral support that clinical evidence shows improves long-term outcomes: semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) achieve 15-22% body weight reduction in clinical trials — but the drugs are expensive ($1,000-$1,300/month list price), require physician oversight, and work best when combined with lifestyle modification that sustains the metabolic changes after medication titration. Fella's subscription model (typically $150-300/month, far below GLP-1 medication list price) achieves the medication access and behavioral support combination by sourcing compounded semaglutide through FDA-registered compounding pharmacies during the branded GLP-1 supply shortage, providing physician prescribing through synchronous and asynchronous telemedicine consultations, and delivering the health coaching that supports sustainable behavior change alongside the medication.

Competitive Landscape 2025–2026

In 2025, Fella Health competes in the men's health telemedicine, GLP-1 obesity treatment, and direct-to-consumer metabolic health market with Ro (men's health telehealth, $876M raised at $5B valuation), Calibrate (metabolic health program, $100M raised), and Hims & Hers (NYSE: HIMS, men's and women's telehealth, $526M revenue 2024) for men with obesity and metabolic health telemedicine program adoption. The $50M+ ARR with $130K in external funding represents one of the most capital-efficient telehealth companies in the GLP-1 obesity treatment market. The cashflow positive milestone (24 months) demonstrates the business model sustainability that VC-heavy telehealth competitors have not yet achieved. The 2025 strategy focuses on the expansion to Fella's 1 million patient milestone, building the metabolic health monitoring platform for longitudinal GLP-1 treatment outcomes tracking, and growing the Delilah women's health brand as a parallel market opportunity.

Revenue
$50M
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Strong Challenger

Fella Health is an established challenger with significant market presence and competitive offerings in Healthcare.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

61
↓ Declining

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

For Fella Health

Claim This Profile

Are you from Fella Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Fella Health Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Fella Health vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →